Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Board of Pharmacy updates controlled‑substances list; bill would add recent fentanyl analogs and allow a psilocybin pharmaceutical exception
Summary
The State Board of Pharmacy told the House Human Services Committee that Senate Bill 20‑64 would update North Dakota's controlled‑substance lists to reflect recent DEA and FDA scheduling actions, including additional fentanyl analogs and synthetic cannabinoids.
The House Human Services Committee heard testimony from the North Dakota State Board of Pharmacy on Senate Bill 20‑64, a biannual scheduling bill intended to align state controlled‑substance lists with recent federal (DEA/FDA) actions.
Mark Hardy, executive director of the State Board of Pharmacy, told the committee the bill "is a biannual bill introduced by the State Board of Pharmacy to bring the Controlled Substance Act up to date with…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
